TP53 and neoplasm: P21 is a target of p53 and exerts its tumor suppressive function by activating p53 through post-translational modifications such as phosphorylation and inhibiting the activity of cyclin–CDK complexes, thereby halting cell proliferation in response to cellular stress or damage [67].